ESLA

Estrella Immunopharma (ESLA)

About Estrella Immunopharma (ESLA)

Estrella Immunopharma, Inc. operates as a pre-clinical stage biopharmaceutical company, which engages in the development of T-cell therapies for patients with cancers and autoimmune diseases. The company was founded on March 30, 2022 and is headquartered in Emeryville, CA.

Details

Daily high

$1.77

Daily low

$1.58

Price at open

$1.60

52 Week High

$3.15

52 Week Low

$0.73

Market cap

63.8M

Dividend yield

0.00%

Volume

108,163

Avg. volume

146,824

P/E ratio

-4.57

Estrella Immunopharma News